Department of Vascular Surgery, Royal Free Hampstead National Health Service Trust Hospital, London, United Kingdom.
J Vasc Surg. 2013 Oct;58(4):1129-39. doi: 10.1016/j.jvs.2013.06.085.
Carotid atheromatous disease is an important cause of stroke and represents a key target in stroke prevention. Randomized trials have shown the efficacy of carotid endarterectomy in secondary stroke prevention. Carotid stenting presents a less invasive alternative to surgical intervention. Advances in medical management, if compliance can be ensured, are leading to improvement in outcomes when implemented as sole therapy in the treatment of atherosclerotic carotid stenosis. This includes lifestyle modification, blood pressure control, and antiplatelet and statin therapy. Over the last 20 years, the annual rate of ipsilateral stroke associated with asymptomatic carotid stenosis has decreased from 2% to 4% to less than 1%. This is largely due to improvements in medical therapy. However, despite numerous trials and years of clinical research, the optimal management of symptomatic and asymptomatic carotid disease remains controversial. This article presents and summarizes the evidence supporting best medical treatment for carotid artery stenosis.
颈动脉粥样硬化性疾病是中风的重要病因,也是中风预防的关键靶点。随机临床试验已经证实颈动脉内膜切除术在二级预防中风中的疗效。颈动脉支架置入术为手术干预提供了一种微创选择。如果能确保患者的依从性,医学治疗的进展可改善动脉粥样硬化性颈动脉狭窄患者的治疗效果,单独应用这些方法治疗时尤其如此。这些进展包括生活方式的改变、血压控制以及抗血小板和他汀类药物治疗。在过去的 20 年中,与无症状性颈动脉狭窄相关的同侧卒中年发生率已从 2%至 4%降至小于 1%。这主要归因于医学治疗的改善。然而,尽管进行了多项试验和多年的临床研究,症状性和无症状性颈动脉疾病的最佳治疗管理仍存在争议。本文介绍并总结了支持颈动脉狭窄最佳药物治疗的证据。